NCT02119247View on ClinicalTrials.gov

Study to Investigate the Pharmacokinetics of CHF 6001 DPI Administered Via Nexthaler® Device or the Capsule for Oral Inhalation Via Aerolizer® Device

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

COPD

Interventions

DEVICE

CHF 6001 dry powder for inhalation via NEXThaler®

DEVICE

CHF 6001 DPI capsules for inhalation via Aerolizer

Trial Locations (1)

B-2060

SGS CPU Antwerpen ZNA Stuivenberg, Antwerp

All Listed Sponsors

lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT02119247 - Study to Investigate the Pharmacokinetics of CHF 6001 DPI Administered Via Nexthaler® Device or the Capsule for Oral Inhalation Via Aerolizer® Device | Biotech Hunter | Biotech Hunter